Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Evoke Pharma, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EVOK
Nasdaq
2834
www.evokepharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Evoke Pharma, Inc.
Here’s Why Evoke Pharma, Inc. (NASDAQ:EVOK) Is Among the Best Diabetes Stocks to Buy Under $10
- Jan 6th, 2025 1:58 pm
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
- Dec 19th, 2024 1:30 pm
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
- Dec 3rd, 2024 1:30 pm
Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations
- Nov 10th, 2024 1:09 pm
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
- Nov 7th, 2024 9:05 pm
Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit
- Nov 4th, 2024 12:52 pm
Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis
- Oct 28th, 2024 5:39 pm
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
- Oct 28th, 2024 11:00 am
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
- Oct 23rd, 2024 12:30 pm
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
- Oct 22nd, 2024 12:30 pm
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
- Oct 1st, 2024 12:30 pm
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
- Sep 19th, 2024 6:20 pm
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
- Sep 9th, 2024 12:30 pm
Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
- Sep 4th, 2024 1:20 pm
Evoke Pharma Second Quarter 2024 Earnings: Misses Expectations
- Aug 15th, 2024 11:57 am
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
- Aug 13th, 2024 12:00 pm
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
- Aug 8th, 2024 12:30 pm
Evoke Pharma, Inc. Announces Reverse Stock Split
- Jul 30th, 2024 12:30 pm
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
- Jun 17th, 2024 12:30 pm
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
- May 16th, 2024 8:02 pm
Scroll